Tokyo, Japan

Seishi Kuwabara

This inventor holds 1 USPTO granted patent. Top assignee: Mitsui Pharmaceuticals, Inc.. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seishi Kuwabara. Retrieved from https://idiyas.com/inventor/seishi-kuwabara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seishi Kuwabara: Innovator in Tuberculosis Research

Introduction

Seishi Kuwabara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of tuberculosis research through his innovative work. His expertise and dedication have led to advancements in understanding and treating this serious disease.

Latest Patents

Kuwabara holds a patent for "Tuberculin active proteins and peptides from the cells of tubercle." This patent focuses on tuberculin active simple proteins and peptides that possess specific peptide linkages. His work in this area is crucial for developing better diagnostic and therapeutic options for tuberculosis.

Career Highlights

Seishi Kuwabara is associated with Mitsui Pharmaceuticals, Inc., where he applies his knowledge and skills to advance pharmaceutical research. His role in the company has allowed him to contribute to significant projects aimed at improving public health.

Collaborations

Kuwabara has worked alongside his coworker, Toru Tsumita, to further enhance the research and development efforts at Mitsui Pharmaceuticals, Inc. Their collaboration has been instrumental in driving innovation within the company.

Conclusion

Seishi Kuwabara's contributions to tuberculosis research through his patent and work at Mitsui Pharmaceuticals, Inc. highlight his importance in the field of medical innovation. His efforts continue to pave the way for advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…